📰 Integrative Screening Process News
Page 3 - Integrative Screening Process News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Integrative Screening Process. Real-time updates on events, politics, business and more.
February 22, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / February 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 22 February 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's recent End-of-Ph...
January 31, 2024
IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast ...
January 31, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / January 31, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the Year-end report for the period January-D...
January 3, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / January 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, January 3, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...
January 3, 2024
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase ...
December 27, 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / December 27, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, December 27, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the appointment of Gunnar Ol...
December 22, 2023
IRLAB Increases its Liquidity with a Loan Facility of Up to SEK 55 ...
December 22, 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)(Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company has entered into a loan agreement of up to SEK 55 million issued by Formue Nord F...
December 21, 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / December 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, December 21, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's drug candidate...
December 21, 2023
IRLAB’s Drug Candidate IRL757 is Phase I Ready